Benzhydrol derivatives for the management of conditions related to hypoxia inducible factors
US10772858B2 · kind B2 · utility
0Cited by
3References
10Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | May 2, 2016 |
| Grant date | Sep 15, 2020 |
| Priority date | — |
| Expiry date | May 2, 2036 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D491/052
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
This disclosure relates to benzhydrol derivatives for managing conditions related to the Hypoxia Inducible Factor (HIF) pathway such as uses in treating cancer. In certain embodiment, the disclosure contemplates compounds and pharmaceutical compositions. In certain embodiment, the disclosure contemplates compounds disclosed herein as prodrugs, optionally substituted with one or more substituents, derivatives, or salts thereof.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.